Biotricity, Inc.

BTCY

US09074H2031

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 02:00:01 12/07/2024 am IST			5-day change	1st Jan Change
0.8998 ^USD	+16.01%		+14.57%	-21.76%

10/07	Biotricity Adds 60-Site, Multi-State Hospital Cardiac Monitoring Pilot Program	CI
27/06	Transcript : Biotricity, Inc., Q4 2024 Earnings Call, Jun 27, 2024

Biotricity, Inc. Reports Sales Results for the Third Quarter of 2018

January 11, 2019 at 06:30 pm IST

Biotricity, Inc. reported sales results for the third quarter of 2018. The company experienced a 211% growth in sales from second quarter 2018 to third quarter 2018.

Latest news about Biotricity, Inc.

Biotricity Adds 60-Site, Multi-State Hospital Cardiac Monitoring Pilot Program	10/07	CI
Transcript : Biotricity, Inc., Q4 2024 Earnings Call, Jun 27, 2024	28/06
Biotricity, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024	27/06	CI
Biotricity, Inc. announced that it has received $0.5 million in funding from Ionic Ventures, LLC	21/06	CI
Biotricity, Inc. Launches Direct-To-Consumer Heart Health Screening Service, Heartsecure, Making Heart Health Services	12/06	CI
Biotricity, Inc. announced that it has received $0.645455 million in funding	15/05	CI
Biotricity Inc. Announces High Demand for Its Latest Device, Biotres Pro	26/04	CI
Top Premarket Decliners	19/04	MT
Biotricity, Inc. announced that it has received $2 million in funding	09/04	CI
Biotricity Announces Strategic Partnership for Cardiac Screenings in Patients with Co-Morbidities	02/04	CI
Biotricity, Inc. announced a financing transaction	25/03	CI
Biotricity Unveils That Improved Margins Resulted from Latest Advancements to Its Proprietary Cardiac Ai Cloud Platform and Announces Plans for Continued Expansion of Its Cardiac AI Cloud	12/03	CI
Biotricity, Inc. Solidifies It's Presence in the Healthcare Landscape	05/03	CI
Transcript : Biotricity, Inc., Q3 2024 Earnings Call, Feb 21, 2024	22/02
Biotricity, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	21/02	CI
Biotricity Inc. Expands Development of its Cardiac AI Cloud Platform with Data Ecosystem of over 360 Billion Heartbeats	23/01	CI
HC Wainwright Downgrades Biotricity to Neutral From Buy	20/11	MT
Transcript : Biotricity, Inc., Q2 2024 Earnings Call, Nov 14, 2023	15/11
Biotricity, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	15/11	CI
Biotricity Releases Another Groundbreaking Product: Biotres Pro	31/23/31	CI
Biotricity Files Patent for Wearable Heart Monitoring Device Bioheart	10/23/10	MT
Biotricity Continues to Expand Patent Portfolio with Latest Patent Filing for Bioheart Device	10/23/10	CI
Biotricity, Inc. Announces Patent Filing for Cutting-Edge Biotres Device	03/23/03	CI
Transcript : Biotricity, Inc., Q1 2024 Earnings Call, Aug 15, 2023	16/23/16
Biotricity, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023	15/23/15	CI

Biotricity Inc. is a medical technology company focused on biometric data monitoring and diagnostic solutions. The Company developed its Bioflux technology, comprised of a monitoring device and software components. The Bioflux device is comprised of a wet electrode worn on a belt clip around the waist. The Bioflux ECG reporting software enables doctors and labs to view a patientâs electrocardiogram (ECG) data for monitoring and diagnostic purposes. Its Bioflux platform has a built-in cellular chipset and a real-time embedded operating system, which allows for its technology to be utilized as an Internet of Things (IoT) platform. It has developed several technologies, including Biotres, Bioheart, and Biocare. Biotres is an ECG Holter solution that addresses the limitations of existing solutions in the Holter market. Bioheart is a personal cardiac monitoring solution for consumers. Biocare is a cardiac disease management platform for chronic care management and remote patient monitoring.

Sector

Advanced Medical Equipment & Technology

Calendar

12/07/2024 - Extraordinary Shareholders Meeting

More about the company